神经分泌生物科学 NBIX 深 沪
已收盘 08-01 16:00:00 美东时间
128.91
+0.680
+0.53%
华盛通- 最 高129.09
- 今 开126.40
- 成交量 139.50万股
- 最 低 124.54
- 昨 收 128.23
- 总市值 127.58亿
- 52周最高 154.865
- 市盈率 静 39.17
- 换手率 1.41%
- 52周最低 84.23
- 委 比 -85.19%
- 总股本 9896.58万
- 历史最高 157.9799
- 量 比 0.94
- 振 幅 3.55%
- 历史最低 5.42
- 每 手 1
- 风险率 12.07%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 罕见！Meta、微软连续获多家大行上调目标价；花旗上调Robinhood目标价升至120美元
今日重点评级关注：丰业银行：维持Arcellx"跑赢大市"评级，目标价从93美元升至133美元；RBC Capital：维持Precision Drilling"跑赢大市"评级，目标价从89美元升至100美元
08-01 10:17
Moderna's Earnings: A Preview
Moderna (NASDAQ:MRNA) is preparing to release its quarterly earnings on Friday,...
07-31 23:02
Wedbush Maintains Outperform on Neurocrine Biosciences, Raises Price Target to $141
Wedbush analyst Laura Chico maintains Neurocrine Biosciences (NASDAQ:NBIX) with a Outperform and raises the price target from $137 to $141.
07-31 21:14
Neurocrine Biosciences shares are trading lower following Q2 reported financial results.
Neurocrine Biosciences shares are trading lower following Q2 reported financial...
07-31 04:41
Preview: United Therapeutics's Earnings
United Therapeutics (NASDAQ:UTHR) is set to give its latest quarterly earnings ...
07-30 00:03
A Look at Incyte's Upcoming Earnings Report
Incyte (NASDAQ:INCY) is set to give its latest quarterly earnings report on Tue...
07-28 23:02
Uncovering Potential: Exelixis's Earnings Preview
Exelixis (NASDAQ:EXEL) is gearing up to announce its quarterly earnings on Mond...
07-25 23:01
Truist Securities Initiates Coverage On Neurocrine Biosciences with Buy Rating, Announces Price Target of $163
Truist Securities analyst Danielle Brill initiates coverage on Neurocrine Biosciences (NASDAQ:NBIX) with a Buy rating and announces Price Target of $163.
07-21 19:58
Neurocrine reports positive results from Crenessity trial
Neurocrine Biosciences (NASDAQ:NBIX) reported one-year results from late-stage study of its experimental drug, Crenessity (crinecerfont), showing reductions in glucocorticoid dose and improvement in a...
07-14 21:37
A Glimpse Into The Expert Outlook On Neurocrine Biosciences Through 14 Analysts
Neurocrine Biosciences (NASDAQ:NBIX) underwent analysis by 14 analysts in the l...
07-10 05:00
